FDA Severe-Bleeding Workshop Addresses Need For Effective Local Agents
This article was originally published in The Gray Sheet
Executive Summary
Panelists at a recent FDA workshop on severe bleeding said there is a need for effective local agents to treat severe bleeding in trauma and surgical cases, and explored a set of primary clinical endpoints for studying the products in rigorous trials.